Urology Solutions Company, Minze Health based in Antwerp, Belgium, has announced that it has received $5.3 million from its existing investors, Capricorn Digital Growth Fund, White Fund, and Flemish investment company PMV. New investor imec.istart future fund has also shown their keen interest and have invested some amount in this round.
Minze Health was founded in the year 2015 and is an ISO 13485:2016 Certified company. Its Chief Executive Officer is Wilfried Woesthuis, who has a lot of experience in International Marketing and is a sales director with a successful history in the medical device and pharma industry, specifically in gynecology, urology, endoscopy, gastroenterology, and ophthalmology.
This funding will help the company to develop and bring PDTs (Prescription Digital Therapeutics) to the desired people facing urinary dysfunctions. The company will focus on France and Germany and will also explore the USA market. The solution by Minze Health has already been used by over 160,000 patients worldwide, and health professionals from across 20+ countries are currently relying on it.
Minze Health will also use this funding for the expansion of its Homeflow and Diary Pod products in the US.
If you are interested in reading healthcare funding news, then check out our other blogs.
Swastik Saraf is the Founder and Managing Editor of TheMedSector. With a background in data journalism and healthcare research, he specializes in aggregating public health metrics, analyzing institutional data, and mapping out regional healthcare infrastructure. Swastik leads the data compilation team at TheMedSector, ensuring all directory tracking is built on verified primary sources before undergoing formal clinical review.
